www.ghtcoalition.org/why-research...
www.ghtcoalition.org/why-research...
Thursday, 4 December at 19:00 ET
🔗 Register here: bit.ly/4nwr4ES
Friday, 5 December at 09:00 ET
🔗 Register here: bit.ly/4ofT6We
Thursday, 4 December at 19:00 ET
🔗 Register here: bit.ly/4nwr4ES
Friday, 5 December at 09:00 ET
🔗 Register here: bit.ly/4ofT6We
www.ghtcoalition.org/blog/researc...
www.ghtcoalition.org/blog/researc...
www.ghtcoalition.org/resources-it...
www.ghtcoalition.org/resources-it...
www.ghtcoalition.org/blog/researc...
www.ghtcoalition.org/blog/researc...
GARDP continues its work to expand access to effective antibiotics and develop innovative treatments so that everyone receives the care they need.
#WorldAIDSDay #AMR
GARDP continues its work to expand access to effective antibiotics and develop innovative treatments so that everyone receives the care they need.
#WorldAIDSDay #AMR
Submit an Expression of Interest to apply for CARB-X funding for new #therapeutics and #diagnostics to address drug-resistant bacteria. The deadline to apply is 12 December at 23:59 ET. 🧪 #AMR #IDSky
🔗 Apply now: bit.ly/3P56UDB
Submit an Expression of Interest to apply for CARB-X funding for new #therapeutics and #diagnostics to address drug-resistant bacteria. The deadline to apply is 12 December at 23:59 ET. 🧪 #AMR #IDSky
🔗 Apply now: bit.ly/3P56UDB
@wacihealth.bsky.social @iasociety.bsky.social
@wacihealth.bsky.social @iasociety.bsky.social
💊Promising #dengue antiviral
🦟Dengue vaccine approval
💉Experimental flu mRNA vaccine
www.ghtcoalition.org/blog/researc...
💊Promising #dengue antiviral
🦟Dengue vaccine approval
💉Experimental flu mRNA vaccine
www.ghtcoalition.org/blog/researc...
💊 Shortened #TB regimen
🧫 New method to combat resistant bacteria using bacteriophages
🦠 Fungal pathogens test
www.ghtcoalition.org/blog/researc...
💊 Shortened #TB regimen
🧫 New method to combat resistant bacteria using bacteriophages
🦠 Fungal pathogens test
www.ghtcoalition.org/blog/researc...
www.ghtcoalition.org/blog/evolvin...
www.ghtcoalition.org/blog/evolvin...
www.ghtcoalition.org/blog/staying...
www.ghtcoalition.org/blog/staying...
www.ghtcoalition.org/blog/researc...
www.ghtcoalition.org/blog/researc...
👥 Learn more and join us in #Rio or virtually! #RethinkRebuildRise
👥 Learn more and join us in #Rio or virtually! #RethinkRebuildRise
📅 25 Nov | 🕛 12:00 GMT
🔗 Register: bit.ly/4i8pYxT
📅 25 Nov | 🕛 12:00 GMT
🔗 Register: bit.ly/4i8pYxT
• The landmark #NeoSep1 trial now spans 9 hospitals across Africa & Asia, testing life-saving antibiotic combos for newborns with sepsis.
• Underway in South Africa, with more sites in preparation.
🔗https://bit.pulse.ly/pvvkvmxmpk
#WAAW2025
• The landmark #NeoSep1 trial now spans 9 hospitals across Africa & Asia, testing life-saving antibiotic combos for newborns with sepsis.
• Underway in South Africa, with more sites in preparation.
🔗https://bit.pulse.ly/pvvkvmxmpk
#WAAW2025
Find out more: unitaid.org/news-blog/wh...
Find out more: unitaid.org/news-blog/wh...
GARDP and Innoviva Specialty Therapeutics have co-developed zoliflodacin, an investigational first-in-class oral antibiotic now under FDA review.
THIS IS BIG.
#WAAW2025 #AMR
and IDT Biologika aims to overcome a major hurdle in vaccine manufacturing: the slow, complex process of potency testing.
and IDT Biologika aims to overcome a major hurdle in vaccine manufacturing: the slow, complex process of potency testing.
estimated US$405 return. Investing in NTDs is not a cost - it's an
economic accelerator. We must protect this progress.
bit.ly/47Hexsl #BeatNTDs #NTDs #EndNTDs
estimated US$405 return. Investing in NTDs is not a cost - it's an
economic accelerator. We must protect this progress.
bit.ly/47Hexsl #BeatNTDs #NTDs #EndNTDs
www.impactglobalhealth.org/insights/rep...
www.impactglobalhealth.org/insights/rep...
www.ghtcoalition.org/rd-across-he...
www.ghtcoalition.org/rd-across-he...
www.washingtonpost.com/health/2025/...
www.washingtonpost.com/health/2025/...
www.ghtcoalition.org/blog/researc...
www.ghtcoalition.org/blog/researc...
www.ghtcoalition.org/blog/staying...
www.ghtcoalition.org/blog/staying...